Novavax

At Novavax, we spark innovation in human health leveraging our technology platform. Our recombinant protein-based nanoparticles and our proprietary Matrix-M? adjuvant work together to induce potent, durable and broad immune responses. Our technology platform provides the foundation for our R&D. Learn more here: https://lnkd.in/edawgWJg #Technology #Biotech

TODAY: John Jacobs, President and Chief Executive Officer, Jim Kelly, Executive Vice President, Chief Financial Officer and Treasurer, and Ruxandra Draghia Akli, MD, PhD, Executive Vice President and Head of Research and Development, will be participating in a Fireside Chat at the Leerink Partners 2025 Global Healthcare Conference in Miami Beach, FL. Event details and webcast information: https://novav.ax/3Fcb7mH

Today we announced changes to our board of directors. James Young, PhD, is retiring as Executive Board Chair and Margaret McGlynn, RPh, has been appointed as his successor. John Shiver, PhD, has been appointed to the board as an independent director.? ? Read our press release: https://lnkd.in/ekQwnmyN

Here's to all the incredible women we get to work with every day at #Novavax. Keep making strides for women and girls in STEM. #IWD2025 #InternationalWomensDay #WomensHistoryMonth

TODAY: John Jacobs, President and Chief Executive Officer, Jim Kelly, Executive Vice President, Chief Financial Officer and Treasurer, and Ruxandra Draghia Akli, MD, PhD, Executive Vice President and Head of Research and Development, will be representing Novavax in a Fireside Chat at the TD Cowen 45th Annual Health Care Conference in Boston, MA. Event details and webcast information: https://lnkd.in/eUF7Htau

At Novavax, we don’t just focus on what we do, we are driven by why we do it. Today, we’re proud to unveil our new Mission and Vision Statements based on our new corporate growth strategy —the compass that steers each decision we make, every innovation we advance, and every collaboration we undertake. Learn more: https://novav.ax/4bfAYX1 #MissionStatement #VisionStatement

Today we shared our financial results and earnings from the fourth quarter and full year 2024. Read the full report: https://novav.ax/43y9pXd ? #Earnings #FinancialResults?

Novavax's conference call to discuss fourth quarter and full year 2024 financial results and operational highlights is today at 8:30 a.m. ET. Register and tune-in at: https://novav.ax/41sFQ7Q

We are actively advancing our pipeline - both late- and early-stage programs - using a rigorous set of principles to guide our selection process and focus on high-value assets in areas with unmet medical need, compelling scientific rationale and strong commercial opportunity. To learn more, click here: https://novav.ax/40Dgm5Z

We are honored to share that the Novavax and Sanofi partnership was selected as the "Top Alliance of 2024" in Citeline's 17th Annual In Vivo Deals of the Year awards. Thank you to the teams that contributed to this work and continue to focus on making Novavax a partner of choice. Learn more: https://novav.ax/41gVfqm